Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infusional 5-fluorouracil with or without mitomycin-C in advanced oesophago-gastric cancer
ISRCTN43866427Phase 3Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jul 1994
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in esophageal cancer and gastric cancer (GC) comparing PVI 5-fluorouracil with PVI 5-fluorouracil plus mitomycin-C (2 arms). Primary endpoints: Tumour response, Survival and 2 more. Started Jul 1994; status: completed.
02
Drugs
fluorouracilmitomycin c
03
Conditions
esophageal cancergastric cancer (GC)
Beyond the preview
Go deeper on ISRCTN43866427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43866427.